Mepolizumab Reduces Exacerbations in Eosinophilic COPD Mepolizumab Reduces Exacerbations in Eosinophilic COPD
Mepolizumab reduced time to first moderate or severe exacerbation in patients with the eosinophilic phenotype of COPD.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Pulmonary Medicine News Source Type: news
More News: Chronic Obstructive Pulmonary | Health